Multiple Sclerosis Treatment in India

Krishna Saxena, a 45-year-old software architect...

Krishna Saxena, a 45-year-old software architect and father of two, first noticed something was wrong during his morning yoga practice. His left leg felt heavy and uncoordinated, a stark contrast to his usual grace. Over the next few months, episodes of debilitating fatigue set in, and he began experiencing strange 'pins and needles' numbness in his hands. A particularly frightening moment came when his vision in one eye became blurry for two weeks. His primary care physician, concerned by these neurologically distinct events, referred him to a neurologist. After a thorough exam and an MRI scan that revealed characteristic lesions on his brain and spinal cord, the neurologist diagnosed him with Relapsing-Remitting Multiple Sclerosis (RRMS). She recommended starting a high-efficacy disease-modifying therapy (DMT) called Ocrelizumab to slow disease progression. The treatment involved biannual intravenous infusions. The first one was anxiety-inducing, but the clinic staff was reassuring. He experienced mild flu-like symptoms after the first dose, which were managed with medication. A year into treatment, Krishna has had no new relapses. The numbness has subsided, and his energy levels are more stable. Emotionally, he journeyed from fear and denial, worrying about his ability to provide for his family, to a place of cautious optimism. The diagnosis was a shock, but the effective treatment has given him a sense of control back. He now sees himself not as a patient defined by MS, but as a person managing a chronic condition, focusing on staying active with his children.